A Randomized, Open-label, Phase 3 Study of Tarlatamab Compared With Standard of Care in Subjects With Relapsed Small Cell Lung Cancer After Platinum-based First-line Chemotherapy (DeLLphi-304)

Arulananda, Surein (Primary Chief Investigator (PCI))

Medicine Monash Health

Project: Research

Project Description

NMA HREC Reference Number: 94160
NMA SSA Reference Number: SSA/94160/MonH-2023-370105(v1)
Monash Health Local Reference: RES-23-0000-079A

Status	Active
Effective start/end date	29/05/23 → 28/05/28